Modern Slavery Policy For Valuemed
Modern slavery policy for Valuemed and Access Diagnostic Tests UK Ltd
This statement is being made in compliance with the Modern Slavery Act 2015 and outlines the ongoing efforts of Access Diagnostic Tests UK Ltd to prevent modern slavery within its business operations, partners and supply chains.
Our commitment
At Valuemed, we are dedicated to eradicating modern slavery and human trafficking from our business operations and supply chains. Our commitment to ethical labour practices and human rights underscores every aspect of our organisation. We firmly condemn all forms of modern slavery and human trafficking, and we are resolute in our efforts to ensure that they have no place within our company. As a company we unequivocally oppose and refuse to engage with any business that is knowingly involved in slavery or human trafficking.
This policy outlines our commitment to ensuring that slavery and human trafficking do not exist in our organisation, partners or supply chain and sets out the steps we take to identify and mitigate these risks.
Valuemed Policy Statement
Valuemed condemns all forms of modern slavery and human trafficking and is committed to upholding human rights and ethical labor practices. We recognise our responsibility to ensure that our operations and supply chains are free from slavery and human trafficking.
Responsibilities
- Management: Valuemed's management is responsible for implementing and overseeing this policy, ensuring that it is effectively communicated to all employees and stakeholders.
- Employees: All employees are expected to familiarise themselves with this policy and report any concerns related to modern slavery or human trafficking.
- Suppliers and Contractors: Valuemed expects its suppliers and contractors to comply with all relevant laws and regulations pertaining to modern slavery and human trafficking. Suppliers and contractors are required to adhere to the principles outlined in this policy.
Risk Assessment
Valuemed conducts regular risk assessments to identify and evaluate the risk of modern slavery and human trafficking within its operations and supply chains. These assessments include evaluating the geographical locations of suppliers, the nature of the products and services provided, and any known instances of modern slavery in the industry.
Due Diligence
Valuemed carries out due diligence on its suppliers and contractors to assess their compliance with this modern slavery policy and their commitment to preventing modern slavery and human trafficking. This may include conducting audits, requesting relevant documentation, and engaging in dialogue with suppliers to address any concerns identified.
Training and Awareness
Valuemed provides training and awareness programs for its employees to ensure they understand the risks of modern slavery and human trafficking and know how to identify and report any suspected cases. Training is provided regularly and covers topics such as recognising the signs of modern slavery, reporting procedures, and the importance of ethical sourcing.
Reporting
Valuemed encourages employees, suppliers, and other stakeholders to report any concerns or suspicions of modern slavery or human trafficking. Reports can be made confidentially and will be investigated promptly and thoroughly.
Compliance and Monitoring
Valuemed monitors compliance with this policy through regular reviews, audits, and assessments of its operations and supply chains. Any instances of non-compliance will be addressed promptly, and corrective actions will be implemented to prevent reoccurrence.
Continuous Improvement
Valuemed is committed to continuously improving its efforts to prevent modern slavery and human trafficking. We regularly review and update this policy to ensure it remains effective and aligned with best practices and legal requirements.
Conclusion
Valuemed is committed to upholding the highest standards of ethical conduct and corporate responsibility. We recognise the importance of combating modern slavery and human trafficking and will continue to work diligently to ensure that our operations and supply chains remain free from these practices.
Date of Approval: 20/3/24
Next Review Date: 20/4/25